{
    "code": 0,
    "data": [
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015; and in continuation to our letter bearing reference no: WOCK/SEC/SE/2025-26/065 dated 4th February 2026 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 10th February2026 inter-alia has approve the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2025;",
            "news_id": "fe3df97c-79a8-4beb-ba47-9d584a408d1e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df5a90e4-ae67-435e-ab91-11731ab9fef9.pdf",
            "news_date": "2026-02-10 14:44:40",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Pursuant to Regulation 30 of SEBI *LODR) Regulation 2015 please find attached herewith un-audited financial results (standalone and consolited) for the quarter and half year ended 30th September 2025.",
            "news_id": "eab4658d-9320-4c6e-b556-08b6575d7812",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de9b0108-a562-499f-92cb-978f4f7e64b9.pdf",
            "news_date": "2025-11-03 15:08:40",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations 2015 We wish to inform you that the Board of Directors at its meeting held today i.e. 8th August 2025 has approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2025.",
            "news_id": "0919e133-ae41-4224-a476-ffdf93f43557",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6c10897-e8de-49ea-8ffc-ae919060aa5f.pdf",
            "news_date": "2025-08-08 14:10:17",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (LODR) Regulations 2015 as amended and in continuation to our letter bearing reference number Ref no: WOCK/SEC/SE/2025-26/012 dated 2nd June 2025 please find enclosed the transcript of the presentation made in the Investor meeting held on Thursday 5th June 2025 for your information and records.",
            "news_id": "b85133eb-7384-45eb-a15c-5d7aaea10cff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c50e942-c9ad-4a5a-840f-10e4b31f502c.pdf",
            "news_date": "2025-06-11 15:33:56",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended and in  continuation of our letter bearing reference number WOCK/SEC/SE/2025-26/012 dated 2nd June 2025 please find enclosed herewith a copy of the updated Investor Presentation.",
            "news_id": "2778e7f8-cda4-421d-88d9-d968219da983",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=163c4bb3-3eeb-4f48-857d-3931854e5e37.pdf",
            "news_date": "2025-06-05 15:11:14",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations 2015 and in continuation to our letter dated 2nd June 2025 Please find enclosed herewith a copy of Investor Presentation to be made at the Investor Meet scheduled to be held today i.e. 5th June 2025.",
            "news_id": "90c50c98-7441-4f3e-b4a8-c47f5e25ce71",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e0435e0-06b2-41bc-8a9a-70ec2534cf18.pdf",
            "news_date": "2025-06-05 09:06:55",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI Listing Regulations 2015 Please find enclosed herewith the Outcome of the Board Meeting held today i.e. 29th May 2025 along with the Audited Standalone and Consolidated Financial Results.",
            "news_id": "0dd617dc-231b-4943-87dd-62adaf42a3d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8a54ea2-502e-4b33-b9f1-cc1d8807cf98.pdf",
            "news_date": "2025-05-29 15:11:32",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to SEBI Listing Regulations 2015 Please find enclosed herewith the Outcome of the Board Meeting held today i.e. 29th May 2025 along with the Audited Standalone and Consolidated financial results for the quarter and year ended 31st March 2025.",
            "news_id": "e761b5a0-009c-4757-b060-afdb8c7a1622",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bd6f3ea-cd91-4926-a06c-63d617ab3dd7.pdf",
            "news_date": "2025-05-29 15:03:46",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter And Half Year Ended September 30, 2024",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we enclose herewith Unaudited Financial Results for the quarter and half year ended September 30, 2024 along with Limited Review Reports thereon.",
            "news_id": "68584f13-bc6f-4a30-b32d-d66d75258860",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d8d0fa0-04b7-44a3-8a31-e3b76de5b3b1.pdf",
            "news_date": "2024-11-13 13:35:48",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed herewith a copy of the Investor Presentation.",
            "news_id": "253c16bc-347e-4459-be68-98085cdbc70b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4621e1ef-09ad-4f6c-aff3-b3eff866e4e1.pdf",
            "news_date": "2024-10-21 09:00:54",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today ie; 9th August, 2024 have approved Unaudited Financial Results for the quarter ended 30th June, 2024 along with the Limited Review Report.",
            "news_id": "90a2ce0b-b65f-42ec-ad52-1f2397ad891c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3cf4371-c2eb-4aef-aa66-fe01c309da8a.pdf",
            "news_date": "2024-08-09 15:19:27",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On May 28, 2024",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, We wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. May, 28, 2024 have approved the matters as attached in the PDF.",
            "news_id": "5cc88b6f-4500-4f70-8b28-3630eb752573",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12bd8d99-7b9e-4c6f-9abb-47f54b181090.pdf",
            "news_date": "2024-05-28 19:38:15",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find herewith a copy of Investor Presentation.",
            "news_id": "ddaf9273-339d-4d4c-84bd-f03b934a9ded",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3413422b-6fcb-4520-88bf-8a86a7fc9de3.pdf",
            "news_date": "2024-02-26 12:21:54",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September, 2023",
            "news_body": "Pursuant to Regulation 30 and 33 of the Listing Regulations read with Schedule III of the Listing Regulations, we enclose herewith Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023 along with the Limited Review Report thereon issued by B S R & Co. LLP Statutory Auditors of the Company as approved in the Board Meeting held on 14.11.2023.",
            "news_id": "92aae4a5-0d59-451e-be85-c9e3ea997c83",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4987095b-c663-487d-a32d-96b3b3a1d57f.pdf",
            "news_date": "2023-11-14 17:50:45",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our letter dated 4th August, 2023, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 14th August, 2023, have approved the unaudited financial results (standalone & consolidated) for the quarter ended 30th June, 2023.",
            "news_id": "5f8c037d-5405-4039-a109-798a78f1b1bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de970dc9-ad87-44ca-91de-abd1a6667984.pdf",
            "news_date": "2023-08-14 14:25:56",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2023-24/034 dated 4th August, 2023, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 14th August, 2023, inter-alia to approve the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2023 and noted the resignation of Mr. Debashis Dey as Company Secretary of the Company with effect from end of working hours on 18th August 2023 and approved the appointment of Ms. Rashmi Mamtura in his place with effect from 19th August 2023.",
            "news_id": "2a53a213-e482-4dd9-9659-901e22d51763",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81fac08c-a3fb-4216-b9c2-efd277ff734f.pdf",
            "news_date": "2023-08-14 14:11:05",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); audited Financial Results of the Company as on March 31, 2023 are enclosed.",
            "news_id": "1da6220d-e388-4dc4-bfe0-ac4d5349fcb3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9f12cef-7fb2-4426-a13b-94c470c321af.pdf",
            "news_date": "2023-05-26 17:25:05",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); outcome of the Board meeting held today i.e. 26th May, 2023 is enclosed.",
            "news_id": "4a8d06f7-00b6-4bc1-9321-0fa6801d1304",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56955f29-5596-4be0-8a97-953434e1c85e.pdf",
            "news_date": "2023-05-26 17:21:53",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and further to our communication dated February 21, 2023, please find enclosed transcript of the investor call.",
            "news_id": "a936cf1e-636c-458a-937d-f3b30ece51df",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e98d36a0-d558-468c-af67-b444a5f94842.pdf",
            "news_date": "2023-02-24 15:58:08",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and further to our communication dated February 14, 2023, we enclose herewith the Investor Presentation discussed during Investor Call held today i.e. Tuesday, February 21, 2023 at 16:00 hrs IST through VC. The Investor Presentation is also available on the website of the Company at the link:https://statutory.wockhardt.com/stock_exchange_disclosures.htmDr. Habil Khorakiwala (Chairman) and Dr. Murtaza Khorakiwala (Managing Director) participated in the Investor Call. The audio - video recording of the Investor Call has been uploaded on the Company's website and the same can be accessed at the link:https://statutory.wockhardt.com/stock_exchange_disclosures.htm",
            "news_id": "796f0bb0-f530-4cc6-a422-3b7f82caec4b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=505a86d4-d851-4739-b561-c9c1018cedc0.pdf",
            "news_date": "2023-02-21 19:21:52",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 13th February, 2023, inter-alia, have approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2022; and Limited Review Report thereon issued by B S R & Co. LLP., Statutory Auditors of the Company; <BR> <BR> Pursuant to Regulations 30 and 33 of Listing Regulations read with Schedule III of Listing Regulations, we enclose herewith the following:<BR> <BR> a. Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended <BR> 31st December, 2022; and Limited Review Report issued by B S R & Co. LLP., Statutory Auditors of the Company (enclosed as Annexure I).<BR> b. A copy of the Press Release proposed to be issued in respect of the said Financial Results (enclosed as Annexure II).<BR>",
            "news_id": "363e84c5-6850-4814-be01-a07f1c608a65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8a2d231-3e23-42d1-840c-06cf4a74e001.pdf",
            "news_date": "2023-02-13 15:15:05",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For Half Year Ended September 30, 2022 Under Reg 23(9) Of SEBI (LODR) Regulations, 2015.",
            "news_body": "Related Party Transactions for Half year ended September 30, 2022 under Reg 23(9) of SEBI (LODR) Regulations, 2015.",
            "news_id": "e49f6ba0-2858-4c25-a20e-905310d11c37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcc77d13-71b6-4048-bf9f-b6a5ef01f63d.pdf",
            "news_date": "2022-11-18 21:18:35",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'); and in continuation to our letter no. Ref. No.: WOCK/SEC/SE/2022-23/044 dated 28th October, 2022, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 4th November, 2022, inter-alia, have approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2022; and Limited Review Report issued by B S R & Co. LLP., Statutory Auditors of the Company; <BR> <BR> <BR> <BR>",
            "news_id": "4527c3c7-88a0-49d3-869e-aca0580b7946",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f21d4cd-c20e-40dd-8f30-82c301f4ddd7.pdf",
            "news_date": "2022-11-04 14:04:41",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2022",
            "news_id": "eda61759-b82a-450c-9abc-a1607b36c3e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e510d73-ac67-4022-9bcb-e3831fc9376c.pdf",
            "news_date": "2022-08-12 16:07:43",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2022",
            "news_id": "08263068-5a94-42cc-a61d-b2a60c27ce34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a99d0d32-a79a-416c-b68e-acf8a74ce632.pdf",
            "news_date": "2022-08-12 15:59:17",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Pursuant To Regulation 23(9) Of Listing Regulations, Please Find Attached The Statement Regarding Disclosure Of Related Party Transactions In The Specified Format For The Half Year Ended 31St March, 2022 Of The Company",
            "news_body": "Pursuant to Regulation 23(9) of Listing Regulations, please find attached the Statement regarding disclosure of Related Party Transactions in the specified format for the half year ended 31st March, 2022 of the Company",
            "news_id": "66e54d97-5df3-4c34-85c6-697667fb38ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c1c1e59-c478-4aa0-8c32-af7fcb8f973c.pdf",
            "news_date": "2022-06-14 17:16:04",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31.03.2022.",
            "news_body": "Audited Financial Results For The Quarter And Year Ended 31.03.2022.",
            "news_id": "cc04be6c-fcde-442b-80a2-5f75ec02299d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2185ec44-697f-4993-8ae8-c4b2b0d03a93.pdf",
            "news_date": "2022-05-30 18:31:49",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith for your information a copy of the latest investor presentation of the Company.",
            "news_id": "69702d99-f0db-4c01-b8e7-9394f77787a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c17371e-4307-4abb-88e5-6d610dceb010.pdf",
            "news_date": "2022-03-08 15:01:57",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2021.",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended 31.12.2021.",
            "news_id": "41c61743-a519-41a4-8037-85950a599a89",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a076850-2067-4e16-9a5a-30da299db196.pdf",
            "news_date": "2022-01-27 12:54:03",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting.",
            "news_body": "Outcome of the Board Meeting held on 27th January, 2022.",
            "news_id": "a7d1b2e7-91d3-4b5c-9296-e275254177df",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e109d8fa-14da-440d-bffb-b8a35825fa95.pdf",
            "news_date": "2022-01-27 12:51:01",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2021.",
            "news_body": "Unaudited Financial Results for the quarter and half year ended 30.09.2021.",
            "news_id": "46d521a6-ce8b-4935-838a-1a029132c4a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f14dfd49-56b5-4c74-a85f-899de98f24ee.pdf",
            "news_date": "2021-11-08 13:44:49",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board Meeting held on 8th November, 2021",
            "news_id": "81477fbc-cc59-4c13-a533-43973231d6e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=991cfecf-b0a4-4fd2-822b-288dcc2a6f7a.pdf",
            "news_date": "2021-11-08 13:42:01",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.06.2021.",
            "news_body": "Unaudited Financial Results for the Quarter ended 30.06.2021.",
            "news_id": "97e54e47-87e0-4847-9407-238f26c6da67",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef03bd64-674b-4e83-871f-e290467a1fe9.pdf",
            "news_date": "2021-07-22 12:51:10",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held Today I.E. 22.07.2021.",
            "news_body": "Outcome of the Board Meeting held today i.e. 22.07.2021.",
            "news_id": "5834db83-c939-4ff4-beac-6f3843e5d8ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7aa3f231-f05a-4393-b0fd-8c9f57269b60.pdf",
            "news_date": "2021-07-22 12:41:54",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions On A Consolidated Basis For The Half Year Ended 31St March, 2021, Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Disclosure of Related Party Transaction on a consolidated basis for the half year ended 31st March, 2021, pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "news_id": "6e2f4762-e2fe-4f9a-b4c4-5deb9fca47fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b64305a5-ebd3-4251-b113-d247180c5467.pdf",
            "news_date": "2021-06-17 18:14:09",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31.03.2021.",
            "news_body": "Audited Financial Results for the quarter and year ended 31.03.2021.",
            "news_id": "91f45c29-3d62-4baa-957d-548d066c475a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d047be4a-2ebc-4f64-94c1-a8f67a730091.pdf",
            "news_date": "2021-05-27 13:55:34",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "WOCKPHARMA",
            "disp": "Wockhardt",
            "bse_code": 532300,
            "isin": "INE049B01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held Today I.E. 27.05.2021.",
            "news_body": "Outcome of the Board Meeting held today i.e. 27.05.2021.",
            "news_id": "12b3e8e6-bace-4452-998b-73d0991b112b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b357a2c-b955-477a-a613-7b5d152fe9e1.pdf",
            "news_date": "2021-05-27 13:50:20",
            "seo": "wockhardt-ltd",
            "ltp": 1402.1,
            "ch": -27,
            "pch": -1.8893009586453013,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 7506,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}